Xenografting of human umbilical mesenchymal stem cells from Wharton ’s jelly ameliorates mouse spinocerebellar ataxia type 1
ConclusionsOur findings provide hope for a new therapeutic direction for the treatment of SCA1.
Source: Translational Neurodegeneration - Category: Neurology Source Type: research
More News: Ataxia | Brain | Genetics | Neurology | Stem Cell Therapy | Stem Cells | Study | Transplants